This site is intended for US healthcare professionals only. Visit Patient Site

LIVING WITH OVERACTIVE BLADDER (OAB)?

MORE TIME HERE LESS TIME THERE

GEMTESA is a prescription medication for the treatment of overactive bladder (OAB) in adults with symptoms of:

  • Urge urinary incontinence (leakage episodes)
  • Urgency
  • Frequency
island image

For Holly Robinson Peete, it was time to become a GEMTESA Go-Getter

Learn More

Actor, real OAB patient, and GEMTESA spokesperson.

Get to know GEMTESA, an overactive bladder medication

Help us help you. Where are you in your OAB journey?

Overactive bladder (OAB) treatment with GEMTESA has its benefits

gif animation

Proven Results

  • Significant reductions seen in all 3 key OAB symptoms* vs placebo (sugar pill) at 12 weeks—including urgency
  • Urgency episodes reduced by half in about 43% of people taking GEMTESA vs 38% of people taking placebo at 12 weeks
Check Out The Science
gif animation

A Simple Routine

  • One single-dose pill taken once daily with or without food
  • Swallow GEMTESA tablets whole with a glass of water
  • In adults, GEMTESA tablets may be crushed, mixed with a tablespoon (~15 mL) of applesauce and taken immediately with a glass of water
Stay On Track
gif animation

No Significant Impact On Blood Pressure

No clinically significant changes to hypertension or increased blood pressure vs placebo

Learn About Safety

*Urgency, frequency, and leakage episodes.

See how Holly stays on track with her GEMTESA treatment plan

Consistency is key when it comes to managing OAB, especially because it's a chronic condition that doesn't just go away overnight.

Holly's name

Actor, real OAB patient, and GEMTESA spokesperson.

Transcript

“As a busy mom, actress, traveler, and advocate, my life is go, go, go. But when overactive bladder–OAB–made it so that all I could think about was, ‘I gotta go, go, go to the bathroom,' I knew I had to make a change.”

[Text on screen] Holly Robinson Peete Actor, real OAB patient, and GEMTESA spokesperson

Holly Robinson Peete is a real patient taking GEMTESA who has been compensated for her participation.

“Luckily, I listened to some of my girlfriends, my body, and, most importantly, my doctor, and found GEMTESA to help manage my OAB symptoms.”

“GEMTESA is a prescription medication for the treatment of overactive bladder in adults with symptoms of leakage episodes, urgency, and frequency.”

[Text on screen] GEMTESA is a prescription medication for the treatment of overactive bladder (OAB) in adults with symptoms of leakage episodes, urgency, and frequency.

“Do not take GEMTESA if you are allergic to vibegron or any of the ingredients in GEMTESA.”

“GEMTESA may cause serious side effects such as increasing your chances of not being able to empty your bladder.”

[Text on screen] GEMTESA may cause serious side effects such as increasing your chances of not being able to empty your bladder. Tell your doctor right away if you are unable to empty your bladder.

“My doctor told me the most common side effects may including headache, urinary tract infection, and common cold symptoms.”

[Text on screen] Most common side effects include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea, and upper respiratory tract infection. Please see Important Safety Information at the end of this video.

“That was over a year ago, and now I'm making it my mission to change what ‘go, go, go,' means in my life and share my experience with others.”

“That's why I became a GEMTESA Go-Getter.”

“A Go-Getter is someone who refuses to let their lives revolve around the bathroom.”

[Text on screen] Quality time with friends

“And it's especially important to spread the word because I know so well that speaking up helps others feel seen and heard.”

“So, help me reframe the go, go, go. I hope you'll: Go — ask your doctor about GEMTESA”

[Text on screen] GO—ask your doctor about [logo] GEMTESA® (vibegron) 75 mg tablets

“Go — talk about your symptoms and explore treatment options”

[Text on screen] GO—talk about your symptoms and explore treatment options

“And Go — become a Go-Getter yourself.”

[Text on screen] Go—become a GO-GETTER yourself.

“Personally, life with GEMTESA means I am comfortable sitting further from the bathroom.”

“So come on, it's time to GO do something about OAB symptoms and become a GEMTESA Go-Getter yourself.”

[Text on screen] TIME TO GO

If you're struggling with OAB symptoms, use the self-assessment tool to start a discussion with your doctor.

Full Prescribing Information can be found at GEMTESA.com/PI

“If you're struggling with OAB symptoms, use the self-assessment tool to start a discussion with your doctor.”

[Narrator voice-over]

IMPORTANT SAFETY INFORMATION

Do not take GEMTESA® (vibegron) if you are allergic to vibegron or any of the ingredients in GEMTESA.

Before you take GEMTESA, tell your doctor about all your medical conditions, including if you have liver problems; have kidney problems; have trouble emptying your bladder or you have a weak urine stream; take medicines that contain digoxin; are pregnant or plan to become pregnant (it is not known if GEMTESA will harm your unborn baby; talk to your doctor if you are pregnant or plan to become pregnant); are breastfeeding or plan to breastfeed (it is not known if GEMTESA passes into your breast milk; talk to your doctor about the best way to feed your baby if you take GEMTESA).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

What are the possible side effects of GEMTESA?

GEMTESA may cause serious side effects including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell your doctor right away if you are unable to empty your bladder.

The most common side effects of GEMTESA include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea and upper respiratory tract infection. These are not all the possible side effects of GEMTESA. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is GEMTESA?

GEMTESA is a prescription medicine for adults used to treat the following symptoms due to a condition called overactive bladder: • urge urinary incontinence: a strong need to urinate with leaking or wetting accidents • urgency: the need to urinate right away • frequency: urinating often It is not known if GEMTESA is safe and effective in children.

Please see full Prescribing Information at www.GEMTESA.com/PI.

GEMTESA® Simple Savings Program

For commercially insured patients, you may pay as little as $0 for each 90-day supply of GEMTESA with the Simple Savings Program!

Limited time offer is valid from January 1, 2023 through December 31, 2024. Restrictions and maximum savings limits apply. Coverage and out-of-pocket costs may vary. Offer not valid for patients participating in Medicare, Medicaid, or other government healthcare programs. See Program Terms, Conditions, and Eligibility Criteria.

 

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

GEMTESA is contraindicated in patients with known hypersensitivity to vibegron or any components of the product.

WARNINGS AND PRECAUTIONS

Urinary Retention

Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder outlet obstruction and patients taking muscarinic antagonist medications for the treatment of OAB. Discontinue GEMTESA in patients who develop urinary retention.

ADVERSE REACTIONS

Most common adverse reactions (2%) reported with GEMTESA were headache, urinary tract infection, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection.

 

INDICATIONS AND USAGE

GEMTESA® is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

GEMTESA is contraindicated in patients with known hypersensitivity to vibegron or any components of the product.

WARNINGS AND PRECAUTIONS

Urinary Retention

Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder outlet obstruction and patients taking muscarinic antagonist medications for the treatment of OAB. Discontinue GEMTESA in patients who develop urinary retention.

ADVERSE REACTIONS

Most common adverse reactions (2%) reported with GEMTESA were headache, urinary tract infection, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection.

Please see full Prescribing Information.

You are encouraged to report side effects and product complaints associated with GEMTESA by calling 1-833-876-8268.

Sumitomo Pharma logo.

is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO PHARMA is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO is a registered trademark of Sumitomo Chemical Co., Ltd., used under license. Sumitomo Pharma America, Inc. is a U.S. subsidiary of Sumitomo Pharma Co., Ltd.

GEMTESA, and the GEMTESA logo are trademarks of Urovant Sciences GmbH, registered in the U.S. and in other countries.

©2024 Sumitomo Pharma America, Inc. All rights reserved. GEM-US-2138-24 09/24

IMPORTANT SAFETY INFORMATION

Do not take GEMTESA if you are allergic to vibegron or any of the ingredients in GEMTESA.

Before you take GEMTESA, tell your doctor about all your medical conditions, including if you have liver problems; have kidney problems; have trouble emptying your bladder or you have a weak urine stream; take medicines that contain digoxin; are pregnant or plan to become pregnant (it is not known if GEMTESA will harm your unborn baby; talk to your doctor if you are pregnant or plan to become pregnant); are breastfeeding or plan to breastfeed (it is not known if GEMTESA passes into your breast milk; talk to your doctor about the best way to feed your baby if you take GEMTESA).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

What are the possible side effects of GEMTESA?
GEMTESA may cause serious side effects including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell your doctor right away if you are unable to empty your bladder.

The most common side effects of GEMTESA include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea and upper respiratory tract infection. These are not all the possible side effects of GEMTESA. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information.

What is GEMTESA?

GEMTESA is a prescription medicine for adults used to treat the following symptoms due to a condition called overactive bladder:

  • urge urinary incontinence: a strong need to urinate with leaking or wetting accidents
  • urgency: the need to urinate right away
  • frequency: urinating often

It is not known if GEMTESA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Do not take GEMTESA if you are allergic to vibegron or any of the ingredients in GEMTESA.

Before you take GEMTESA, tell your doctor about all your medical conditions, including if you have liver problems; have kidney problems; have trouble emptying your bladder or you have a weak urine stream; take medicines that contain digoxin; are pregnant or plan to become pregnant (it is not known if GEMTESA will harm your unborn baby; talk to your doctor if you are pregnant or plan to become pregnant); are breastfeeding or plan to breastfeed (it is not known if GEMTESA passes into your breast milk; talk to your doctor about the best way to feed your baby if you take GEMTESA).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

What are the possible side effects of GEMTESA?
GEMTESA may cause serious side effects including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell your doctor right away if you are unable to empty your bladder.

The most common side effects of GEMTESA include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea and upper respiratory tract infection. These are not all the possible side effects of GEMTESA. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information.

You are encouraged to report side effects and product complaints associated with GEMTESA by calling 1-833-876-8268.

Sumitomo Pharma logo

is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO PHARMA is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO is a registered trademark of Sumitomo Chemical Co., Ltd., used under license. Sumitomo Pharma America, Inc. is a U.S. subsidiary of Sumitomo Pharma Co., Ltd.

GEMTESA, and the GEMTESA logo are trademarks of Urovant Sciences GmbH, registered in the U.S. and in other countries.

©2024 Sumitomo Pharma America, Inc. All rights reserved. GEM-US-2115-24 09/24